HYBOGYN Contraceptive Tablet - Vietnam Registration 220000022/PCBA-HD
Access comprehensive regulatory information for HYBOGYN Contraceptive Tablet in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi A medical device is registered under number 220000022/PCBA-HD and manufactured by Pulipha Pharmaceutical Corporation.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Technical Details
Supports and reduces the symptoms of fungal and bacterial infections in cases of vaginitis, cervical ectropion, etc. Helps women eliminate abnormal vaginal discharge and reduce itching and odor in the genital area. Helps to balance the pH in the vagina and promotes the regeneration of the epithelial cells in the genital area. Helps to tighten and strengthen the vagina, and improve its color and elasticity.
Dates and Status
Feb 18, 2022